Related Experiment Video
Updated: Mar 12, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability
Haili Wu1, Peng Yang1, Wanglai Hu2
1Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China.
Abstract:
M2-type pyruvate kinase (PKM2) contributes to the Warburg effect. However, it remains unknown as to whether PKM2 has an inhibitory effect on mitochondrial function. We report in this work that PKM2 overexpression inhibits the expression of Drp1 and results in the mitochondrial fusion. The ATP production was found to be decreased, the mtDNA copy number elevated and the expression level of electron transport chain (ETC) complex I, III, V depressed in PKM2 overexpressed cells. PKM2 overexpression showed a decreased p53 protein level and a shorter p53 half-life. In contrast, PKM2 knockdown resulted in increased p53 expression and prolonged half-life of p53. PKM2 could directly bind with both p53 and MDM2 and promote MDM2-mediated p53 ubiquitination. The dimeric PKM2 significantly suppressed p53 expression compared with the other PKM2 mutants. The reverse relationship between PKM2 and Drp1 was further confirmed in a large number of clinical samples. Taken together, the present results highlight a new mechanism that link PKM2 to mitochondrial function, based on p53-Drp1 axis down regulation, revealing a novel therapeutic target in patients with abnormal mitochondria.
Insights
Pyruvate kinase M2 (PKM2) overexpression inhibits mitochondrial function by downregulating p53 and Drp1. This PKM2-p53-Drp1 axis offers a new therapeutic target for mitochondrial disorders.
Area of Science:
- Cell Biology
- Mitochondrial Biology
- Cancer Metabolism
Background:
- Pyruvate kinase M2 (PKM2) is known to promote the Warburg effect in cancer.
- The impact of PKM2 on mitochondrial function remains largely unexplored.
Purpose of the Study:
- To investigate the role of PKM2 in regulating mitochondrial function.
- To elucidate the molecular mechanisms linking PKM2 to mitochondrial dynamics and cellular metabolism.
Main Methods:
- Overexpression and knockdown of PKM2 in cellular models.
- Analysis of mitochondrial morphology, ATP production, mtDNA copy number, and electron transport chain (ETC) complex expression.
- Western blotting and co-immunoprecipitation to assess protein levels and interactions (p53, MDM2, Drp1).
- Analysis of clinical samples to confirm PKM2-Drp1 relationship.
Main Results:
- PKM2 overexpression led to mitochondrial fusion, decreased ATP production, elevated mtDNA copy number, and reduced ETC complex expression.
- PKM2 overexpression suppressed p53 levels and half-life by promoting MDM2-mediated ubiquitination.
- PKM2 directly binds to p53 and MDM2, with dimeric PKM2 showing stronger suppression of p53.
- A negative correlation between PKM2 and Drp1 expression was observed in clinical samples.
Conclusions:
- PKM2 inhibits mitochondrial function through the downregulation of the p53-Drp1 axis.
- This study reveals a novel mechanism connecting PKM2 to mitochondrial dysfunction.
- The PKM2-p53-Drp1 pathway represents a potential therapeutic target for diseases involving mitochondrial abnormalities.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

